✦ LIBER ✦

Inhibition of P-Glycoprotein: Rapid Assessment of Its Implication in Blood-Brain Barrier Integrity and Drug Transport to the Brain by an In Vitro Model of the Blood-Brain Barrier

✍ Scribed by Laurence Fenart; Valeric Buée-Scherrer; Laurence Descamps; Christian Duhem; Marie-Gwenaëlle Poullain; Roméo Cecchelli; Marie-Pierre Dehouck

Book ID: 110305209
Publisher: Springer US
Year: 1998
Tongue: English
Weight: 782 KB
Volume: 15
Category: Article
ISSN: 0724-8741
DOI: 10.1023/a:1011913723928

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of P-glycoprotein inhib

Pharmacokinetics of P-glycoprotein inhibition in the rat blood-brain barrier

✍ Stina Syvänen; Andrew Hooker; Obaidur Rahman; Helena Wilking; Gunnar Blomquist; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

This article describes the experimental set-up and pharmacokinetic modeling of P-glycoprotein function in the rat blood-brain barrier using [ 11 C]verapamil as the substrate and cyclosporin A as an inhibitor of P-gp. [ 11 C]verapamil was administered to rats as an i.v. bolus dose followed by graded

5 In vitro studies of S9788 as a reversi

5 In vitro studies of S9788 as a reversing agent of P-glycoprotein dependent drug transport across the blood-brain barrier

✍ L. Fenart; M. G. Poullain; B. Giroux; R. Cecchelli; M. P. Dehouck 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 92 KB

Glucose Transporter 1, Distribution in t

Glucose Transporter 1, Distribution in the Brain and in Neural Disorders: Its Relationship With Transport of Neuroactive Drugs Through the Blood-Brain Barrier

✍ Guo Xiuli; Geng Meiyu; Du Guanhua 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 96 KB

Evaluation of drug efflux transporter li

Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood–brain and blood–ocular barriers

✍ Donald W. Miller; Martha Hinton; Fang Chen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Abstract ## Aims The objective of the present study was to evaluate drug efflux transporter interactions of darifenacin and examine the impact of such transporter interactions on darifenacin permeability in an __in vitro__ model of the blood–brain barrier (BBB) and blood–ocular barrier (BOB).

Development of a P-glycoprotein knockout

Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood–brain barrier

✍ Leanne Cutler; Colin Howes; Nigel J. Deeks; Tania L. Buck; Phil Jeffrey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

The objective of this study was to establish the optimal blood concentrations of the potent P-glycoprotein (P-gp) inhibitor GF120918 (Elacridar) required to achieve maximal knockout of this efflux transporter in the blood-brain barrier (BBB) of mice, rats, and guinea pigs. Genetic mdr1a/b(-/-) knock

Enhanced cerebral uptake of receptor lig

Enhanced cerebral uptake of receptor ligands by modulation of P-glycoprotein function in the blood–brain barrier

✍ P. Doze; A. Van Waarde; P.H. Elsinga; N.H. Hendrikse;; W. Vaalburg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Low cerebral uptake of some therapeutic drugs can be enhanced by modulation of P-glycoprotein (P-gp), an ATP-driven drug efflux pump at the blood-brain barrier (BBB). We investigated the possibility of increasing cerebral uptake of the beta-adrenergic ligands S-1'-[(18)F]-fluorocarazolol (FCAR) and